Broadcom’s AI Backbone & Salesforce’s 29% Leap 03/27/26
/
RSS Feed
Broadcom’s AI Backbone & Salesforce’s 29% Leap 03/27/26
Key Stories:
- Marvell Technology, a key player in data infrastructure, is showing some impressive numbers in the semiconductor space. The company is experiencing 30% growth while trading at 26 times earnings. Investors have been intensely focused on the AI compute war, often spotlighting giants like Nvidia and AMD, as well as the hyperscale cloud providers building their own custom chips. But Marvell is certainly making its mark in this rapidly expanding landscape, particularly with its contributions to AI at the edge. This points to the increasing importance of underlying infrastructure providers beyond the immediate spotlight, and what investors should be watching in the broader AI ecosystem. Read more
- Sticking with the critical infrastructure for artificial intelligence, Broadcom, the diversified semiconductor and software company, remains a powerful, though sometimes underappreciated, force behind the AI buildout. Despite facing a significant pullback, falling more than 24% from its December 2025 highs, Broadcom has still delivered a robust performance over the past year, climbing over 62% in the last 12 months. Its role across custom AI silicon, high-speed networking, and infrastructure software continues to deepen as hyperscalers expand their AI capabilities. Analysts remain bullish on Broadcom, seeing its position in the AI boom as increasingly durable, suggesting potential long-term value for investors looking past the recent dip. Read more
- Now, let’s pivot from hardware to the software side of the AI story with Salesforce, the cloud-based customer relationship management giant. Analyst sentiment is notably bullish on Salesforce, with a strong 75% of coverage maintaining “Buy” ratings. The consensus price target stands at $255, suggesting a compelling 29.34% upside potential for the stock. This positive outlook is fueled by Salesforce’s new AI product launches and recent insider purchases, reinforcing confidence in the company’s strategic direction. As the company continues to integrate AI across its platforms, investors will be watching closely to see how these innovations translate into sustained growth and market share gains. Read more
- Moving away from the tech sector for a moment, let’s turn our attention to healthcare giant Johnson & Johnson. The diversified pharmaceutical and consumer health company is seeing an upward trend in analyst price targets. While a recent fair value estimate saw a modest bump from $237.29 to $241.08, several bullish analysts are now discussing even higher price targets, ranging from $250 to $280. This shift is primarily driven by specific product drivers and the company’s strong sector positioning. Investors should keep an eye on how these evolving targets align with Johnson & Johnson’s upcoming earnings and product pipeline news for future growth indicators. Read more
- Finally today, we have an interesting update in the consumer defensive space. Freshpet, the company known for its fresh, refrigerated pet food, has received an upgrade to ‘Outperform’ from Oppenheimer. This positive re-rating comes with a target price of $80 for the stock, implying an almost 24% upside from current levels. The upgrade follows a period where the stock had pulled back due to concerns over competition, particularly from big box retailers like Costco. This analyst move suggests renewed confidence in Freshpet’s market position and growth prospects, making it a stock to watch for those interested in the mid-cap consumer sector. Read more
Keywords: AI, AMD, AVGO, CRM, FRPT, JNJ, MRVL, Nvidia, Oppenheimer, analyst ratings, analyst targets, bullish, cloud computing, competition, consumer defensive, earnings, fair value, growth, healthcare, hyperscalers, infrastructure, insider purchases, networking, pet food, pharmaceuticals, price target, product drivers, pullback, sector positioning, semiconductors, software, target price, upgrade, upside, upside potential